Genetic Abnormalities and Biological Changes of Panic Disorder Patients After Pharmacotherapy

Samsung Medical Center

Status: Unknown

Conditions: Panic Disorder

Study type: Observational

Funder types: Other

Identifiers

NCT00515996

C-A6-418-2

Details and patient eligibility

About

We plan to examine genetic polymorphism of catechol-O-methyltransferase in panic disorder and neurobiological changes of panic disorder patients after 12 weeks of pharmacotherapy with paroxetine. We plan to include 40 panic disorder patients and 40 normal control subjects in this study for 3 years.

Enrollment: 80 estimated patients

Sex: All

Ages: 20 to 60 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Panic disorder

Exclusion criteria

• Other major medical or psychiatric illnesses

Trial design

80 participants in 1 patient group

2

Description:

paroxetine treatment group vs. normal control group